Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Akero Therapeutics Inc buy Morgan Stanley

Akero Therapeutics Inc
Start price
€14.00
11.10.23 / 50%
Target price
€31.05
11.10.24
Performance (%)
92.86%
End price
€27.00
12.10.24
Summary
This prediction ended on 12.10.24 with a price of €27.00. The BUY prediction by Morgan_Stanley for Akero Therapeutics Inc saw massive gains of 92.86%. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Akero Therapeutics Inc - - -
iShares Core DAX® 1,72 % 3,37 % 5,89 %
iShares Nasdaq 100 -4,56 % -4,24 % 21,39 %
iShares Nikkei 225® -7,12 % -11,87 % 42,36 %
iShares S&P 500 -0,89 % 1,69 % 19,49 %

Comments by Morgan_Stanley for this prediction

In the thread Akero Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 92.86%
Target price 31.053
Change
Ends at 11.10.24

Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target lowered by analysts at Morgan Stanley from $70.00 to $33.00. They now have an "overweight" rating on the stock.
Ratings data for AKRO provided by MarketBeat

Morgan Stanley 
0
Report Share
11.10.23
In the thread Trading Akero Therapeutics Inc
Prediction Buy
Perf. (%) 92.86%
Target price 31.053
Change
Ends at 11.10.24

Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten

Morgan Stanley 
0
Report Share
12.10.24

Stopped prediction by Morgan_Stanley for Akero Therapeutics Inc

buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€38.28
10.03.25
-
10.03.26
22.70%
11.03.26

Morgan Stanley 
10.03.25 50%
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€49.44
28.01.25
€92.02
28.01.26
-5.00%
29.01.26

Morgan Stanley 
28.01.25 50%